Minerva Neurosciences
NERV
#8613
Rank
NZ$0.32 B
Marketcap
NZ$7.55
Share price
1.64%
Change (1 day)
99.56%
Change (1 year)

Market capitalization of Minerva Neurosciences (NERV)

Market cap: NZ$0.32 Billion

As of January 2026 Minerva Neurosciences has a market cap of NZ$0.32 Billion. This makes Minerva Neurosciences the world's 8613th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Minerva Neurosciences from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.32 B4.34%
2025NZ$0.31 B1017.16%
2024NZ$28.02 M-58.79%
2023NZ$68 M408.54%
2022NZ$13.37 M-73.31%
2021NZ$50.09 M-63.84%
2020NZ$0.13 B-66.42%
2019NZ$0.41 B5.46%
2018NZ$0.39 B18.68%
2017NZ$0.32 B-44.16%
2016NZ$0.59 B169.3%
2015NZ$0.21 B54.75%
2014NZ$0.14 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Minerva Neurosciences was reported to be:

NZ$0.32 Billion
by Nasdaq info icon info icon
NZ$0.32 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Clovis Oncology
CLVS
NZ$20.47 M-93.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$35.79 B 10,857.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
NZ$3.20 B 880.36%๐Ÿ‡บ๐Ÿ‡ธ USA